{"id":49971,"date":"2022-10-24T12:01:50","date_gmt":"2022-10-24T10:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/"},"modified":"2022-10-24T12:01:50","modified_gmt":"2022-10-24T10:01:50","slug":"g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/","title":{"rendered":"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<b><i><span class=\"bwuline\">New solution to empower accurate interpretation of Next-Generation Sequencing data<\/span><\/i><\/b>\n<\/li>\n<li>\n<b><i><span class=\"bwuline\">Expanded offerings to make personalized treatment options a reality in UAE and region<\/span><\/i><\/b>\n<\/li>\n<\/ul>\n<p>ABU DHABI, United Arab Emirates&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/genomics?src=hash\" target=\"_blank\" rel=\"noopener\">#genomics<\/a>&#8211;In a step aimed at boosting its clinical genomics capabilities in the region and beyond, <b>G42 Healthcare,<\/b> Abu Dhabi-based leading AI health-tech company, has announced a partnership with <b>Saphetor SA<\/b>, a Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/5\/Saphetor_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/21\/Saphetor_Logo.jpg\"><\/a><\/p>\n<p>\nThe collaboration is a pivotal step in G42 Healthcare\u2019s strategy to support the health of future generations, in addition to reinforcing the UAE\u2019s reputation as the hub for global innovation and research in the field of clinical genomics.\n<\/p>\n<p>\nSaphetor\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsaphetor.com%2Fvarsome-editions%2Fvarsome-clinical%2F&amp;esheet=52950864&amp;newsitemid=20221024005472&amp;lan=en-US&amp;anchor=VarSome+Clinical&amp;index=1&amp;md5=4506114382b78968d1ff2e06ad3c3981\" rel=\"nofollow noopener\" shape=\"rect\">VarSome Clinical<\/a> \u2013 a clinically-certified cloud-based platform empowering fast and accurate variant discovery, annotation, and interpretation of Next Generation Sequencing data \u2013 complements G42 Healthcare\u2019s robust capabilities of sequencing data more rapidly and precisely, helping biologists, geneticists, and doctors to push the boundaries of healthcare innovation and discovery.\n<\/p>\n<p>\nEnhancing these new capabilities is part of G42 Healthcare\u2019s mission to provide insights and facilitate early diagnosis and treatment of cancer, rare and metabolic diseases, and other genetic conditions in the region. The company recently launched over 250 comprehensive clinical genetic testing panels that use state-of-the-art sequencing technologies, with the shortest turnaround time. This collaboration also enables clinical genomics, at scale, as a service, using G42 Healthcare\u2019s 3 genomic sequencing platforms offering both long and short read capabilities.\n<\/p>\n<p>\nVarSome Clinical\u2019s accurate variant calling and world-leading annotation and variant classification capabilities, coupled with Saphetor\u2019s sophisticated implementation capabilities, make it a perfect fit for G42 Healthcare to cater to the strong data regulations in place in the region for genomic data.\n<\/p>\n<p>\nCommenting on the partnership, Ashish Koshy said: \u201cG42 Healthcare is committed to pushing the boundaries of innovation to enable us to continually offer innovative solutions across the entire healthcare value chain. The collaboration will fortify G42 Healthcare\u2019s clinical genomics\u2019 solutions by leveraging the VarSome suite of bioinformatics tools to deliver valuable data insights and improved outcomes. This partnership is a pivotal step in our efforts to reinforce UAE\u2019s reputation as the regional hub of innovation in healthcare and life sciences.\u201d\n<\/p>\n<p>\nAndreas Massouras, CEO and Founder of Saphetor SA, said: \u201cSince its inception, Saphetor is committed to enabling accurate molecular diagnosis at scale for a wide range of disorders through identification and interpretation of human genomic variants by leveraging proprietary algorithms and expert domain knowledge. VarSome is an extremely valuable resource to support clinical decisions as well as for clinical genomics research in delivering comprehensive genome data, biological insights, and healthcare outcomes for better personalized and preventive healthcare delivery. At Saphetor, we are all excited for our technology to serve the people of the UAE and beyond via our partnership with G42 Healthcare\u201d.\n<\/p>\n<p>\nVarSome Clinical is powered by a comprehensive molecular database of 140 curated and aggregated genomic data sources and is additionally supported by a vast library of linked publications and comments from a global community of over 500,000 users of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvarsome.com%2F&amp;esheet=52950864&amp;newsitemid=20221024005472&amp;lan=en-US&amp;anchor=VarSome.com&amp;index=2&amp;md5=2a28941266689ab1731e28b7573a6a8a\" rel=\"nofollow noopener\" shape=\"rect\">VarSome.com<\/a>. The platform applies recognized global interpretation standards to germline and somatic variants to produce pathogenicity classifications in real-time.\n<\/p>\n<p>\nG42 Healthcare has built the region\u2019s largest Omics Centre of Excellence which leverages advanced sequencing technologies for short and long reads, making it a partner of choice for governments, research institutes, hospitals, and omics centers. This capability helps G42 Healthcare offer state-of-the-art clinical genetic sequencing services across the disease spectrum \u2013 from acute to chronic to lifestyle.\n<\/p>\n<p>\n<b>-End-<br \/>\n<br \/><\/b><b>About G42 Healthcare<br \/>\n<br \/><\/b><i>G42 Healthcare, a leading health-tech company, is on a mission to develop a world-class healthcare sector in the UAE and beyond, by harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care and transforming the traditional healthcare ecosystem. We have built Biogenix Labs, UAE\u2019s first COVID-19 accredited large-scale throughput laboratory, facilitated the 4Humanity clinical trials, the world\u2019s first phase three trial for inactivated vaccine against COVID-19 with over 43,000 volunteers from 125+ nationalities across the pan-Arab region, established the region\u2019s first dedicated contract research organization (IROS) for conducting clinical research with and for local populations, supported UAE\u2019s healthcare authorities on the national vaccination implementation, conducted research into new vaccines and drug therapies, and built Omics Centre of Excellence, the region\u2019s largest and most technologically advanced Omics facility that is the backbone for the Emirati Genome Program, the world\u2019s most comprehensive population genomics initiative.<br \/>\n<br \/><\/i><i>For further information on G42 Healthcare, visit <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.g42healthcare.ai&amp;esheet=52950864&amp;newsitemid=20221024005472&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.g42healthcare.ai&amp;index=3&amp;md5=9b49066efead31fd577f9be6dc287026\" rel=\"nofollow noopener\" shape=\"rect\"><i>https:\/\/www.g42healthcare.ai<\/i><\/a>\n<\/p>\n<p>\n<b>About Saphetor SA<br \/>\n<br \/><\/b><i>Saphetor SA, is a global precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge.<br \/>\n<br \/><\/i><i>Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions both for clinicians and researchers. VarSome.com professional community and search engine is freely accessible, featuring a widely-recognized community-driven knowledge base that enables flexible queries across more than <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fvarsome.com%2Fdatasources%2F&amp;esheet=52950864&amp;newsitemid=20221024005472&amp;lan=en-US&amp;anchor=140+genetic+and+genomic+data+resources&amp;index=4&amp;md5=503d1eaeea4a966fa308f10736155bb5\" rel=\"nofollow noopener\" shape=\"rect\"><i>140 genetic and genomic data resources<\/i><\/a><i>.<br \/>\n<br \/><\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Flanding.varsome.com%2Fvarsome-premium&amp;esheet=52950864&amp;newsitemid=20221024005472&amp;lan=en-US&amp;anchor=VarSome+Premium&amp;index=5&amp;md5=0d436e3f77c984cd00a9abb6db204694\" rel=\"nofollow noopener\" shape=\"rect\"><i>VarSome Premium<\/i><\/a><i> and <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Flanding.varsome.com%2Fvarsome-clinical&amp;esheet=52950864&amp;newsitemid=20221024005472&amp;lan=en-US&amp;anchor=VarSome+Clinical&amp;index=6&amp;md5=e24a0ca84e39482124784bd8e5402844\" rel=\"nofollow noopener\" shape=\"rect\"><i>VarSome Clinical<\/i><\/a><i> are professional editions of VarSome with powerful functionality and further sophisticated data-mining and analysis tools. VarSome Clinical is a CE-IVD-certified and HIPAA-compliant platform allowing fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels, which helps clinicians reach faster and more accurate diagnoses and treatment decisions for genetic conditions. VarSome can also be integrated into existing in-house pipelines via VarSome API through cloud-based or on premises installations.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<i>For more information contact:<\/i>\n<\/p>\n<p>\n<i>Carl Smith<\/i><br \/><i>Marketing Manager<\/i><br \/><i>Saphetor<\/i><br \/><i>E: <a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#99;&#x61;&#114;&#x6c;&#46;&#x73;m&#105;&#x74;&#104;&#x40;s&#x61;p&#104;&#x65;&#116;&#x6f;r&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">carl&#46;&#115;&#109;&#105;&#116;&#x68;&#x40;&#x73;&#x61;&#x70;&#x68;&#x65;tor&#46;&#99;&#111;&#109;<\/a><\/i><br \/><i>T: +44 (0) 7515 820918<\/i>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>New solution to empower accurate interpretation of Next-Generation Sequencing data Expanded offerings to make personalized treatment options a reality in UAE and region ABU DHABI, United Arab Emirates&#8211;(BUSINESS WIRE)&#8211;#genomics&#8211;In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49971","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New solution to empower accurate interpretation of Next-Generation Sequencing data Expanded offerings to make personalized treatment options a reality in UAE and region ABU DHABI, United Arab Emirates&#8211;(BUSINESS WIRE)&#8211;#genomics&#8211;In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-24T10:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/21\/Saphetor_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation\",\"datePublished\":\"2022-10-24T10:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/\"},\"wordCount\":945,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005472\\\/en\\\/1611101\\\/21\\\/Saphetor_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/\",\"name\":\"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005472\\\/en\\\/1611101\\\/21\\\/Saphetor_Logo.jpg\",\"datePublished\":\"2022-10-24T10:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005472\\\/en\\\/1611101\\\/21\\\/Saphetor_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221024005472\\\/en\\\/1611101\\\/21\\\/Saphetor_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/","og_locale":"en_US","og_type":"article","og_title":"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation - Pharma Trend","og_description":"New solution to empower accurate interpretation of Next-Generation Sequencing data Expanded offerings to make personalized treatment options a reality in UAE and region ABU DHABI, United Arab Emirates&#8211;(BUSINESS WIRE)&#8211;#genomics&#8211;In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-24T10:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/21\/Saphetor_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation","datePublished":"2022-10-24T10:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/"},"wordCount":945,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/21\/Saphetor_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/","url":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/","name":"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/21\/Saphetor_Logo.jpg","datePublished":"2022-10-24T10:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/21\/Saphetor_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221024005472\/en\/1611101\/21\/Saphetor_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/g42-healthcare-strengthens-clinical-genomics-offering-with-saphetors-varsome-bioinformatics-platform-strengthens-uaes-position-as-a-global-leader-in-healthcare-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"G42 Healthcare Strengthens Clinical Genomics Offering with Saphetor\u2019s VarSome Bioinformatics Platform, Strengthens UAE\u2019s Position as a Global Leader in Healthcare Innovation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49971"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49971\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}